Regeneron Pharmaceuticals

Últimas notícias

Manchetes no idioma original da fonte.

• This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking (abre em uma nova aba)

  2 de out. de 2026

• 
  Sanofi, Regeneron Expand Immunology Alliance With New Antibodies (abre em uma nova aba)

  2 de out. de 2026

• 
  Sanofi pays Regeneron up to $8B to expand immunology alliance (abre em uma nova aba)

  2 de out. de 2026

• Friday Five: Sanofi and Regeneron (re)partner up in the face of Dupixent's patent cliff, AstraZeneca invests $2B in Summit, Lilly delivers more weight loss wins…and more (abre em uma nova aba)

  FirstWord Pharma · 2 de out. de 2026

• Regeneron (REGN) Stock May Be Underpriced Despite Its $1b Alliance Expansion (abre em uma nova aba)

  Simply Wall Street · 1 de out. de 2026

• Vertex Pharmaceuticals And 2 Other Top Gene Therapy Stocks (abre em uma nova aba)

  1 de out. de 2026

• Why Regeneron (REGN) Stock Is Trading Lower Today (abre em uma nova aba)

  Yahoo Finance · 1 de out. de 2026

• OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD (abre em uma nova aba)

  1 de out. de 2026

• Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day (abre em uma nova aba)

  MarketWatch · 1 de out. de 2026

• Regeneron, Sanofi Expand Alliance in Deal Worth Up to $8 Billion (abre em uma nova aba)

  MarketBeat · 1 de out. de 2026

• Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent (abre em uma nova aba)

  MedCity News · 1 de out. de 2026

• Sanofi To Pay Regeneron Up To $8B In Immunology Alliance (abre em uma nova aba)

  Law360 · 1 de out. de 2026

• Sanofi And Regeneron Expand Immunology Alliance In Deal Worth Up To $8 Billion (abre em uma nova aba)

  pulse2.com · 1 de out. de 2026

• Regeneron Pharmaceuticals (NDQ:REGN): Is This Dark Horse The TSMC Of The Pharmaceutical Sector? (abre em uma nova aba)

  Stocks Down Under · 1 de out. de 2026

• Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $930.00 (abre em uma nova aba)

  MarketBeat · 1 de out. de 2026

• Regeneron Pharmaceuticals (REGN) Reports Promising Ubamatamab Tr (abre em uma nova aba)

  GuruFocus · 1 de out. de 2026

• Regeneron Pharmaceuticals (REGN) Reports Promising Phase 1/2 Tri (abre em uma nova aba)

  GuruFocus · 1 de out. de 2026

• Regeneron posts trial data for ovarian cancer therapy (REGN:NASDAQ) (abre em uma nova aba)

  Seeking Alpha · 1 de out. de 2026

• Regeneron Pharmaceuticals (REGN) Unveils Positive Phase 2 COURAG (abre em uma nova aba)

  GuruFocus · 1 de out. de 2026

• Regeneron, Sanofi Expand Alliance with $1 Billion Upfront, 4 Antibodies (abre em uma nova aba)

  BioPharm International · 1 de out. de 2026

• Regeneron Pharmaceuticals Says Ubamatamab Show 73% Objective Response Rate & 11-Month Median PFS In LGSOC Patients (abre em uma nova aba)

  TradingView · 1 de out. de 2026

• Sanofi, Regeneron broaden alliance to find their next Dupixent (abre em uma nova aba)

  1 de out. de 2026

• Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC) (abre em uma nova aba)

  1 de out. de 2026

• Phase 2 COURAGE Trial Confirms Trevogrumab Prevents Lean Mass and Muscle Loss During GLP-1 Receptor Agonist-induced Weight Loss (abre em uma nova aba)

  1 de out. de 2026

• Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion (abre em uma nova aba)

  Benzinga · 1 de out. de 2026

• Pfizer’s eczema drug clears skin in mid-stage trial (abre em uma nova aba)

  1 de out. de 2026

• Kodiak Sciences More Than Doubles on Eye Disease Trial Results (abre em uma nova aba)

  1 de out. de 2026

• Regeneron Pharmaceuticals, Inc. (REGN) Discusses Expanded Collaboration on Next-Generation Long-Acting Immunology Antibodies - Slideshow (NASDAQ:REGN) 2026-10-01 (abre em uma nova aba)

  Seeking Alpha · 1 de out. de 2026

• Regeneron and Sanofi Expand Antibody Alliance with Four New Drugs (abre em uma nova aba)

  Pharmaceutical Executive · 1 de out. de 2026

• Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal (abre em uma nova aba)

  1 de out. de 2026